Stocks · Health care · Pharmaceutical Preparations

IONIS PHARMACEUTICALS INC

IONS Clue Score40
United States Fiscal year ends December CIK 0000874015 Results filed 29 Jul 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Allene M. Diaz
7 Jul 2026
Director
Sold after exercise
10,111
$85.42
$863.64K
Joseph Klein III
1 Jul 2026
Director
Sold after exercise
11,419
$79.04
$902.55K
Joseph Klein III
1 Jul 2026
Director
Sold after exercise
99
$79.45
$7.87K
Brett P Monia
26 Jun 2026
Chief Executive Officer
Sold after exercise
50,000
$80.59
$4.03M
Eugene Schneider
26 Jun 2026
EVP, Chf Clinical Develop Ofcr
Sold after exercise
26,000
$81.05
$2.11M
Joseph Baroldi
26 Jun 2026
EVP, Chief Business Officer
Sold after exercise indirect
5,635
$80.16
$451.70K
Brett P Monia
25 Jun 2026
Chief Executive Officer
Sold after exercise
21,072
$78.49
$1.65M
Brett P Monia
24 Jun 2026
Chief Executive Officer
Sold after exercise
14,565
$78.41
$1.14M
Spencer R Berthelsen
15 Jun 2026
Director
Sold after exercise
8,000
$73.49
$587.92K
Holly B. Kordasiewicz
12 Jun 2026
EVP, Chief Development Officer
Sold after exercise
19,842
$74.05
$1.47M
Holly B. Kordasiewicz
12 Jun 2026
EVP, Chief Development Officer
Sold after exercise
41,004
$73.09
$3.00M
Spencer R Berthelsen
1 Jun 2026
Director
Sold after exercise
8,000
$75.67
$605.36K
Brett P Monia
14 May 2026
Chief Executive Officer
Sold after exercise
3,220
$78.68
$253.35K
Brett P Monia
13 May 2026
Chief Executive Officer
Sold after exercise
1,316
$78.01
$102.67K
Joseph Loscalzo
4 May 2026
Director
Sold after exercise
17,781
$75.58
$1.34M
Joseph Loscalzo
4 May 2026
Director
Sold after exercise
59,508
$74.90
$4.46M
Joseph Klein III
1 May 2026
Director
Sold after exercise
1,431
$74.45
$106.53K
Joseph Klein III
1 May 2026
Director
Sold after exercise
8,680
$73.35
$636.70K
Joseph Klein III
1 Apr 2026
Director
Sold after exercise
2,216
$75.95
$168.31K
Joseph Klein III
1 Apr 2026
Director
Sold after exercise
20,105
$75.50
$1.52M
Elizabeth L Hougen
16 Mar 2026
EVP, Finance & CFO
Sold after exercise
9,440
$72.77
$686.90K
Elizabeth L Hougen
16 Mar 2026
EVP, Finance & CFO
Sold after exercise
205,608
$72.38
$14.88M
Kyle Jenne
10 Mar 2026
EVP, Chf GL Pdt Str Ofcr
Sold after exercise
16,086
$76.30
$1.23M
Kyle Jenne
10 Mar 2026
EVP, Chf GL Pdt Str Ofcr
Sold after exercise
21,191
$75.50
$1.60M
Brett P Monia
10 Mar 2026
Chief Executive Officer
Sold after exercise
17,591
$76.34
$1.34M
Brett P Monia
10 Mar 2026
Chief Executive Officer
Sold after exercise
16,512
$75.47
$1.25M
Brett P Monia
9 Mar 2026
Chief Executive Officer
Sold after exercise
1,684
$75.58
$127.28K
Brett P Monia
9 Mar 2026
Chief Executive Officer
Sold after exercise
117,604
$75.26
$8.85M
Brett P Monia
9 Mar 2026
Chief Executive Officer
Sold after exercise
7,382
$74.11
$547.09K
Joseph Baroldi
4 Mar 2026
EVP, Chief Business Officer
Sold after exercise indirect
201
$80.00
$16.08K
Joseph Baroldi
4 Mar 2026
EVP, Chief Business Officer
Sold after exercise indirect
238
$80.00
$19.04K
Joseph Loscalzo
4 Mar 2026
Director
Sold after exercise
200
$80.00
$16.00K
Joseph Baroldi
3 Mar 2026
EVP, Chief Business Officer
Sold after exercise indirect
36
$81.01
$2.92K
Joseph Baroldi
3 Mar 2026
EVP, Chief Business Officer
Sold after exercise indirect
2,088
$80.41
$167.89K
Joseph Baroldi
3 Mar 2026
EVP, Chief Business Officer
Sold after exercise
4,096
$79.36
$325.06K
C Frank Bennett
3 Mar 2026
EVP, Chief Scientific Officer
Sold after exercise
802
$80.76
$64.77K
C Frank Bennett
3 Mar 2026
EVP, Chief Scientific Officer
Sold after exercise
12,687
$79.88
$1.01M
C Frank Bennett
3 Mar 2026
EVP, Chief Scientific Officer
Sold after exercise
71,600
$79.10
$5.66M
Shannon L. Devers
3 Mar 2026
EVP, Chief Human Resources Ofc
Sold after exercise
755
$80.84
$61.03K
Shannon L. Devers
3 Mar 2026
EVP, Chief Human Resources Ofc
Sold after exercise
5,030
$80.00
$402.39K
Shannon L. Devers
3 Mar 2026
EVP, Chief Human Resources Ofc
Sold after exercise
14,321
$79.12
$1.13M
Allene M. Diaz
3 Mar 2026
Director
Sold after exercise
1,005
$80.80
$81.20K
Allene M. Diaz
3 Mar 2026
Director
Sold after exercise
14,608
$79.88
$1.17M
Allene M. Diaz
3 Mar 2026
Director
Sold after exercise
39,265
$79.11
$3.11M
Joseph Klein III
3 Mar 2026
Director
Sold after exercise
1,012
$80.82
$81.79K
Joseph Klein III
3 Mar 2026
Director
Sold after exercise
6,794
$80.00
$543.49K
Joseph Klein III
3 Mar 2026
Director
Sold after exercise
13,526
$79.17
$1.07M
Joseph Loscalzo
3 Mar 2026
Director
Sold after exercise
832
$80.33
$66.83K
C Frank Bennett
2 Feb 2026
EVP, Chief Scientific Officer
Sold after exercise
16,463
$83.03
$1.37M
C Frank Bennett
2 Feb 2026
EVP, Chief Scientific Officer
Sold after exercise
48,626
$83.03
$4.04M
C Frank Bennett
2 Feb 2026
EVP, Chief Scientific Officer
Sold after exercise
20,000
$82.60
$1.65M
Shannon L. Devers
7 Jan 2026
EVP, Chief Human Resources Ofc
Sold after exercise
9,264
$84.62
$783.92K
Shannon L. Devers
7 Jan 2026
EVP, Chief Human Resources Ofc
Sold after exercise
3,829
$84.62
$324.01K
Shannon L. Devers
7 Jan 2026
EVP, Chief Human Resources Ofc
Sold after exercise
3,460
$84.62
$292.79K
Shannon L. Devers
7 Jan 2026
EVP, Chief Human Resources Ofc
Sold after exercise
2,101
$85.36
$179.34K
Shannon L. Devers
7 Jan 2026
EVP, Chief Human Resources Ofc
Sold after exercise
25,545
$85.36
$2.18M
Eric Swayze
2 Jan 2026
EVP Research
Sold after exercise
18,338
$79.27
$1.45M
Eric Swayze
2 Jan 2026
EVP Research
Sold after exercise
5,125
$78.57
$402.67K
Shannon L. Devers
25 Nov 2025
EVP, Chief Human Resources Ofc
Sold after exercise
16,777
$80.91
$1.36M
Joseph Klein III
25 Nov 2025
Director
Sold after exercise indirect
4,000
$80.00
$320.00K
Joseph Klein III
25 Nov 2025
Director
Sold after exercise indirect
4,000
$80.00
$320.00K
Joseph Klein III
25 Nov 2025
Director
Sold after exercise indirect
4,000
$80.00
$320.00K
Joan E Herman
19 Nov 2025
Director
Sold after exercise
32,000
$72.13
$2.31M
Joan E Herman
19 Nov 2025
Director
Sold after exercise
12,000
$72.13
$865.59K
Richard S Geary
6 Nov 2025
EVP, Chief Development Officer
Sold after exercise
18,300
$75.42
$1.38M
Richard S Geary
6 Nov 2025
EVP, Chief Development Officer
Sold after exercise
14,738
$76.10
$1.12M

What was left out

Form 4 filings counted 101
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 66
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 1,631,784
History held since 10 Oct 2006